Issue 8/2016
Content (8 Articles)
Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges
Sevan Dirmesropian, James G. Wood, C. Raina MacIntyre, Philippe Beutels, Anthony T. Newall
Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions
Emma Frew
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective
P. Thokala, E. L. Simpson, P. Tappenden, J. W. Stevens, K. Dickinson, S. Ryder, P. Harrison
Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension
Shuyan Gu, Huimei Hu, Hengjin Dong
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions
Catrin O. Plumpton, Daniel Roberts, Munir Pirmohamed, Dyfrig A. Hughes
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial
Lars Oddershede, Simon Walker, Wolfgang Stöhr, David T. Dunn, Alejandro Arenas-Pinto, Nicholas I. Paton, Mark Sculpher
The Impact of Different DCE-Based Approaches When Anchoring Utility Scores
Richard Norman, Brendan Mulhern, Rosalie Viney
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Jonathan Graham, Doreen McBride, Donald Stull, Anna Halliday, Stamatia Theodora Alexopoulos, Maria-Magdalena Balp, Matthew Griffiths, Ion Agirrezabal, Torsten Zuberbier, Alan Brennan